Brightens glutathione the color of the eyes

Treat age-related macular degeneration naturally with micronutrient medicine

Age-Related Eye Disease Study Research Group (2006): A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. AREDS Report No. 8. Arch Ophthalmol 2001; 119 (10): 1417-36. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1462955/, accessed on: December 21, 2018.

Age-Related Eye Disease Study 2 Research Group (2013): Lutein + zeaxanthin an omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA 2013; 309 (19): 2005-15. https://www.ncbi.nlm.nih.gov/pubmed/23644932, accessed on: December 21, 2018.

Age-Related Eye Disease Study 2 Research Group (2015): Secondary analysis of the effects of lutein / zeaxanthin on age-related macular degeneration progression AREDS2 Report No. 3. JAMA Ophthalmol 2014; 132 (2): 142-49. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636082/, accessed on: December 21, 2018.

Ates, O. et al. (2008): The effect of L-carnitine treatment on levels of malondialdehyde and glutathione in patients with age-related macular degeneration. Eurasian J Med 2008; 40 (1): 1-5. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261317/, accessed on: December 21, 2018.

Professional Association of Ophthalmologists in Germany (BVA) et al. (2014): Current statement of the German Ophthalmological Society, the Retinological Society and the Professional Association of Ophthalmologists in Germany on dietary supplements for age-related macular degeneration (AMD). Status October 2014. http://cms.augeninfo.de/fileadmin/stellunghaben/zu_Nahrungsergaenzungsmittel_bei_AMD_Oktober_2014.pdf, accessed on: December 21, 2018.

Federal Institute for Risk Assessment (2005): Beta-carotene in food supplements. Opinion No. 019/2005 of the BfR of March 8, 2005, amended on January 21, 2013. https://mobil.bfr.bund.de/cm/343/beta_carotin_in_nahrungsergaenzungsmittel.pdf, accessed on: December 21, 2018.

Biesalski, H.K. et al. (2010): Nutritional Medicine. 4th edition. Georg Thieme Verlag Stuttgart.

Biesalski, H.K. (2016): Vitamins and Minerals. Indication, diagnosis, therapy. Georg Thieme Verlag Stuttgart New York.

Browling, B. (2017): Kanski's Ophthalmology. A systematic approach. 8th edition Elsevier Munich.

Carneiro, A. et al. (2017): Nutritional and lifestyle Interventions for age-related macular degeneration: a review. Oxid Med Cell Longev 2017; 2017: 6469138. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244028/, accessed on: December 21, 2018.

Erie, J.C. et al. (2009): Reduced zinc and copper in the retinal pigment epithelium and chorioid in age-related macular degeneration. Am J Ophthalmol 2009; 147 (2): 276-82. https://www.ncbi.nlm.nih.gov/pubmed/18848316, accessed on: December 21, 2018.

Evans, J.R. et al. (2017): Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database Syst Rev 2017; 7: CD000254. https://www.ncbi.nlm.nih.gov/pubmed/28756618, accessed on: December 21, 2018.

Evans, J.R. et al. (2017): Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. Cochrane Database Syst Rev 2017; 7: CD000253. https://www.ncbi.nlm.nih.gov/pubmed/28756617, accessed on: December 21, 2018.

Feher, J. et al. (2005): Improvement of visual functions and fundus alterations in early age-related macular degeneration treated with a combination of acetyl-L-carnitine, n-3-fatty acids, and coenzyme Q10. Ophthalmologica 2005; 219 (39: 154-66. Https://www.ncbi.nlm.nih.gov/pubmed/15947501, accessed on: December 21, 2018.

Gopinath, B. et al. (2018): Dietary flavonoids and the prevalence and 15-y incidence of age-related macular degeneration. Am J Clin Nutr 2018; 108 (2): 381-87. https://www.ncbi.nlm.nih.gov/pubmed/29982448, accessed on: December 21, 2018.

Gröber, U. (2011): Micronutrients. Metabolic Tuning - Prevention - Therapy. 3rd edition. Wissenschaftliche Verlagsgesellschaft mbH Stuttgart.

Gröber, U. (2015): Interactions, Drugs and Micronutrients. 2nd edition. Scientific publishing company Stuttgart.

Gröber, U. (2018): Drugs and Micronutrients - Medication-Oriented Supplementation. 4th edition. Wissenschaftliche Verlagsgesellschaft Stuttgart.

Huang, Y.M. et al. (2015): Effect of supplemental lutein and zeaxanthin on serum, macular pigmentation and visual performance in patients with early age-related macular degeneration. Biomed Res Int 2015; 2015: 564738. https://www.ncbi.nlm.nih.gov/pubmed/25815324, accessed on: December 21, 2018.

Ma, L. et al. (2012): Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration. Ophthamology 2012; 119 (11): 2290-7. https://www.ncbi.nlm.nih.gov/pubmed/22858124, accessed on: December 21, 2018.

Merle, B.M.J. et al. (2015): CFH Y402H and ARMS A69S polymorphisms and oral supplementation with docosahexaenoic acid in neovascular age-related macular degeneration patients: The NAT2 study. PLoS One 2015; 10 (7): e0130816. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489493/, accessed on: December 21, 2018.

Munch, I.C. et al. (2016): Precursors of age-related macular degeneration: associations with vitamin A and interaction with CFHY402H in the Inter99 Eye Study. Acta Ophthalmol 2016; 94 (7): 657-62. https://www.ncbi.nlm.nih.gov/pubmed/27502478, accessed on: December 21, 2018.

PRO RETINA Germany e. V. (2018): Simulation of eye diseases and visual impairments. Online information, as of October 19, 2018. https://www.pro-retina.de/simulation/makuladegeneration, accessed on: December 21, 2018.

PRO RETINA Germany e. V. (2018): Information on lutein and zeaxanthin intake. Online information, as of October 19, 2018. https://www.pro-retina.de/forschungsfoerderung/wissenschaftliche-beratungsgremien/empfänger/lutein-und-zeaxanthin, accessed on: December 21, 2018.

Qu, J. et al. (2009): Coenzyme Q10 in the human retina. Invest Ophthalmol Vis Sci 2009; 50 (4): 1814-8. https://www.ncbi.nlm.nih.gov/pubmed/19060288, accessed on: December 21, 2018.

Querques, G. et al. (2016): Dynamic drusen remodeling in participants of the Nutritional AMD Treatment-2 (NAT-2) randomized trial. PLoS One 2016; 11 (2): e0149219. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762680/, accessed on: December 21, 2018.

Qin, L. et al. (2014): Patients with early age-related macular degeneration exhibit signs of macro- and micro-vascular disease and abnormal glutathione levels. Graefes Arch Clin Exp Ophthalmol 2014; 252 (1): 23-30. https://www.ncbi.nlm.nih.gov/pubmed/23842712, accessed on: December 21, 2018.

Saari, J.C. (2016): Vitamin A and vision. Subcell Biochem 2016; 81: 231-59. https://www.ncbi.nlm.nih.gov/pubmed/27830507, accessed on: December 21, 2018.

Sabour-Pickett, S. et al. (2014): Supplementation with three different macular carotenoid formulations in patients with early age-related macular degeneration. Retina 2014; 34 (9): 1757-66. https://www.ncbi.nlm.nih.gov/pubmed/24887490, accessed on: December 21, 2018.

Schleicher, M. et al. (2013): Diminising risk for age-related macular degeneration with nutrition: a current view. Nutrients 2013; 5 (7): 2405-56. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738980/, accessed on: December 21, 2018.

Smailhodzic, D. et al. (2014): Zinc supplementation inhibits complement activation in age-related macular degeneration. PLoS One 2014; 9 (11): e112682. https://www.ncbi.nlm.nih.gov/pubmed/25393287, accessed on: December 21, 2018.

Sparrow, J.R. et al. (2016): Vitamin A-aldehyde adducts: AMD risk and targeted therapeutics. Prox Natl Acad Sci USA 2016; 113 (17): 4564-69. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855581/, accessed on: December 21, 2018.

Souied, E.H. et al. (2016): Omega-3 fatty acids and age-related macular degeneration. Ophthalmic Res 2016; 55: 62-69. https://www.karger.com/Article/FullText/441359, accessed on: December 21, 2018.

Tan, L.X. et al. (2016): Protective responses to sublytic complement in the retinal pigment epithelium. Proc Natl Acad Sci USA 2016; 113 (31): 8789-94. https://www.ncbi.nlm.nih.gov/pubmed/27432952, accessed on: December 21, 2018.

Wolf-Schnurrbusch, U.E. et al. (2015): Oral lutein supplementation enhances macular pigment density and contrast sensitivity but not in combination with polyunsaturated fatty acids. Invest Ophthalmol Vis Sci 2015; 56 (13): 8069-74. https://www.ncbi.nlm.nih.gov/pubmed/26720458, accessed on: December 21, 2018.

Wu, J. et al. (2015): Intakes of lutein, zeaxanthin, and other carotenoids and age-related macular degeneration during 2 decades of prospective follow-up. JAMA Ophthalmol 2015; 133 (12): 1415-24. https://www.ncbi.nlm.nih.gov/pubmed/26447482, accessed on: December 21, 2018.